Glatt enters into biopharma equipment business
We are delighted to announce a significant achievement for Glatt: the successful manufacturing of bioprocessing suites for insulin production for a client in Egypt. With the successful Factory Acceptance Test (FAT), this project marks our first venture in the bioprocessing sector outside of Asia, demonstrating our ability to meet diverse market demands while maintaining the highest standards of quality, innovation, and regulatory compliance.